Skip to content

Clinical Study on the Treatment of Post-Stroke Oral-Phase Dysphagia by Jinjin (EX-HN12) and Yuye (EX-HN13) Pricking Combined with Repetitive Transcranial Magnetic Stimulation

Clinical Study on the Treatment of Post-Stroke Oral-Phase Dysphagia by Jinjin (EX-HN12) and Yuye (EX-HN13) Pricking Combined with Repetitive Transcranial Magnetic Stimulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000979
Enrollment
Unknown
Registered
2026-04-16
Start date
2025-06-26
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke dysphagia

Interventions

Control group:Jinjin and Yuye pricking
Observation group:Jinjin and Yuye pricking Combined with Repetitive Transcranial Magnetic Stimulation

Sponsors

Ganzhou Nankang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who meet the diagnostic and syndrome differentiation criteria, regardless of gender, aged 40–80 years; patients and their family members have signed the informed consent form; vital signs are stable and the patient is conscious; swallowing disorder is assessed by the Kubota Water Swallowing Test as moderate (Level III) or severe (Level IV)

Exclusion criteria

Exclusion criteria: 1: Patients with a history of swallowing disorders 2: those with swallowing disorders induced by other factors such as medication or myasthenia gravis 3: patients with a history of surgery in the pharyngeal region 4: and those with concurrent failure of important organs such as the liver and kidneys.

Design outcomes

Primary

MeasureTime frame
Oral Function Rating Scale ;

Secondary

MeasureTime frame
Kubota Water Swallowing Test ; Functional Oral Intake Scale ;

Countries

China

Contacts

Public ContactChen Lixue

Ganzhou Nankang Hospital of Traditional Chinese Medicine

403813649@qq.com15007092813

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026